A randomized phase III trial comparing sorafenib plus best supportive care (BSC) versus BSC alone in Child-Pugh B patients (pts) with advanced hepatocellular carcinoma (HCC): The BOOST study

被引：0
|
作者：
Daniele, Bruno
Di Maio, Massimo
Gallo, Ciro
Gasbarrini, Antonio
Carteni, Giacomo
Di Costanzo, Giovan Giuseppe
Craxi, Antonio
Cabibbo, Giuseppe
Bolondi, Luigi
Granito, Alessandro
Missale, Gabriele
Frassoldati, Antonio
Angelico, Mario
Roselli, Mario
Daniele, Gennaro
Perrone, Francesco
机构：
[1] G Rummo Hosp, Benevento, Italy
[2] Natl Canc Inst, Clin Trials Unit, Naples, Italy
[3] Univ Naples 2, Naples, Italy
[4] Policlin Univ Agostino Gemelli, Rome, Italy
[5] Azienda Osped Rilievo Nazl A Cardarelli, Naples, Italy
[6] Azienda Osped Univ, Policlin Paolo Giaccone, Palermo, Italy
[7] Azienda Osped Univ Policlin St Orsola Malpighi, Bologna, Italy
[8] Azienda Osped Univ Parma, Parma, Italy
[9] Az Osped Univ Arcispedale St Anna Ferrara, Ferrara, Italy
[10] Azienda Osped Univ Policlin Tor Vergata, Rome, Italy
[11] Natl Canc Inst, Naples, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4151
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A randomized phase III trial comparing pemetrexed plus best supportive care (BSC) vs BSC in previously treated patients (PTS) with advanced malignant pleural mesothelioma (MPM)
    Jassem, Jacek
    Ramlau, Rodryg
    Santoro, Armando
    Schuette, Wolfgang
    Chemaissani, Assad
    Hong, Shengyan
    Blatter, Johannes
    Adachi, Susumu
    Hanauske, Axel-R
    Manegold, Christian
    ANNALS OF ONCOLOGY, 2006, 17 : 214 - 214
  • [2] Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase III study
    Ciuleanu, T. E.
    Brodowicz, T.
    Belani, C. P.
    Kim, J.
    Krzakowski, M.
    Laack, E.
    Wu, Y.
    Peterson, P.
    Adachi, S.
    Zielinski, C. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] CCTG CO.26 trial: A phase II randomized study of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with advanced refractory colorectal carcinoma (rCRC).
    Chen, Eric Xueyu
    Jonker, Derek J.
    Kennecke, Hagen F.
    Berry, Scott R.
    Couture, Felix
    Ahmad, Chaudhary E.
    Goffin, John R.
    Kavan, Petr
    Harb, Mohammed
    Colwell, Bruce
    Samimi, Setareh
    Samson, Benoit
    Abbas, Tahir
    Aucoin, Nathalie
    Aubin, Francine
    Koski, Sheryl L.
    Wei, Alice Chia-chi
    Magoski, Nadine M.
    Tu, Dongsheng
    O'Callaghan, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [4] Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis
    Blanc, Jean-Frederic
    Khemissa, Faiza
    Bronowicki, Jean-Pierre
    Monterymard, Carole
    Perarnau, Jean-Marc
    Bourgeois, Vincent
    Obled, Stephane
    Abdelghani, Meher Ben
    Mabile-Archambeaud, Isabelle
    Faroux, Roger
    Seitz, Jean-Francois
    Locher, Christophe
    Senellart, Helene
    Villing, Anne-Laure
    Audemar, Franck
    Costentin, Charlotte
    Deplanque, Gael
    Manfredi, Sylvain
    Edeline, Julien
    HEPATOLOGY INTERNATIONAL, 2021, 15 (01) : 93 - 104
  • [5] Phase IIb randomized trial of JX-594, a targeted multimechanistic oncolytic vaccinia virus, plus best supportive care (BSC) versus BSC alone in patients with advanced hepatocellular carcinoma who have failed sorafenib treatment (TRAVERSE)
    Burke, James M.
    Breitbach, Caroline
    Patt, Richard H.
    Lencioni, Riccardo
    Homerin, Michel
    Limacher, Jean-Marc
    Lusky, Monika
    Hickman, Theresa
    Longpre, Lara
    Kirn, David H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] A multicenter, randomized phase III trial comparing second-line chemotherapy (SLC) plus best supportive care (BSC) with BSC alone for pretreated advanced gastric cancer (AGC)
    Park, S. H.
    Lim, D. H.
    Park, K.
    Lee, S.
    Oh, S. Y.
    Kwon, H.
    Kang, J. H.
    Hwang, I. G.
    Lee, J.
    Park, J. O.
    Park, Y. S.
    Lim, H. Y.
    Kang, W. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] The NCIC CTG and AGITG CO.23 trial: A phase III randomized study of BBI608 plus best supportive care (BSC) versus placebo (PBO) plus BSC in patients (Pts) with pretreated advanced colorectal carcinoma (CRC).
    Jonker, Derek J.
    Nott, Louise M.
    Yoshino, Takayuki
    Li, Chiang
    Gill, Shariene
    Shapiro, Jeremy David
    Ohtsu, Atsushl
    Zalcberg, John Raymond
    Vickers, Michael M.
    Slims, John
    Wei, Alice Chia-Chi
    Mittmann, Nicole
    Magoski, Nadine M.
    Murray, Yvonne
    Tsobanis, Eric
    Tu, Dongsheng
    Kerstein, David
    O'Callaghan, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (HCC): Safety and efficacy in Child-Pugh (CP) class A and B patients
    Pressiani, Tiziana
    Boni, Corrado
    Rimassa, Lorenza
    Labianca, Roberto
    Fagiuoli, Stefano
    Ardizzoni, Andrea
    Foa, Paolo
    Cortesi, Enrico
    Giordano, Laura
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] Phase II randomized trial on dose-escalated sorafenib (S) versus best supportive care (BSC) in patients with advanced hepatocellular carcinoma (HCC) with disease progression on prior S treatment.
    Pressiani, T.
    Rimassa, L.
    Boni, C.
    Labianca, R.
    Fagiuoli, S.
    Ardizzoni, A.
    Foa, P.
    Cortesi, E.
    Porta, C.
    Artioli, F.
    Latini, L.
    Carnaghi, C.
    Lutman, R. F.
    Torzilli, G.
    Tommasini, M.
    Ceriani, R.
    Covini, G.
    Giordano, L.
    Locopo, N.
    Santoro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Abou-Alfa, Ghassan K.
    Qin, Shukui
    Ryoo, Baek-Yeol
    Lu, Sheng-Nan
    Yen, Chia-Jui
    Feng, Yin-Hsun
    Lim, Ho Yeong
    Izzo, Francesco
    Colombo, Massimo
    Sarker, Debashis
    Bolondi, Luigi
    Vaccaro, Gina M.
    Harris, William Proctor
    Chen, Zhendong
    Hubner, Richard
    Meyer, Tim
    Bomalaski, John S.
    Lin, ChenChun
    Chao, Yee
    Chen, Li-Tzong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345